Lyxor has cross-listed its Lyxor Scientific Beta Developed Long/Short UCITS ETF onto Xetra and Börse Frankfurt under ticker code GLMN GY where it trades in euros.

Investors should pay more attention to market exposure when conducting analyses of smart beta strategies, according to research from ERI Scientific Beta. Noël Amenc, CEO of ERI Scientific Beta, said, “Market beta adjustment corresponds best to a relative risk budgeting approach and as such is surely recommended for investors who are concerned about replacing an active manager.”

Lyxor has launched the Lyxor Scientific Beta Developed Long/Short UCITS ETF, providing exposure to an equity market neutral index that is composed of a long position in a number of portfolios designed to maximise exposure to different factors and a short position in a broad market capitalization-weighted index.

Smart beta index provider ERI Scientific Beta has announced that assets tracking its indices reached $25 billion at the end of December 2017, up substantially from 30 June 2017 when assets under replication amounted to $16bn. Professor Noël Amenc, CEO of Scientific Beta, said, “[The indices] remain based on the double diversification of factor and specific risks, and do not sacrifice the latter in favour of a concentrated portfolio optimised in-sample.”

ERI Scientific Beta, a smart beta index provider and affiliate of EDHEC-Risk Institute, has jumped to the defence of factor-index investing in a strong rebuttal of a report published by investment consultants Mercer. Noël Amenc, CEO of ERI Scientific Beta, said the Mercer report was “representative of undocumented opinions on factor investing and as such is liable to misinform investors.”

ERI Scientific Beta, an affiliate of the EDHEC-Risk Institute, and Fundlogic, the ETF platform of investment bank Morgan Stanley, have partnered to launch five smart beta ETFs on the London Stock Exchange. The ETFs provide factor-based equity exposure to the US, Japan, developed Asia-Pacific ex-Japan, developed Europe, and emerging markets.

The Desjardins Emerging Markets Multifactor-Controlled Volatility ETF (DFE CN), launched on the Toronto Stock Exchange, complements the firm’s existing suite of three multifactor funds which includes ETFs providing exposure to US, Canadian, and developed international equities. Nicolas Richard, chief operating officer at Desjardins, said, “We are now in a position to offer our unique and innovative construction strategy for all of the major markets of the world.”

The MS Scientific Beta Global Equity Factors UCITS ETF (GEF LN) has recorded significant inflows, gaining approximately $270 million in net new assets in Q3 2017.

ERI Scientific Beta has launched a long/short equity market neutral index that takes a long position in a number of portfolios designed to maximise exposure to different factors while shorting the broad cap-weighted market. The succinctly-named Scientific Beta Developed Multi-Beta Multi-Strategy Managed Volatility L/S Equity Market Neutral Index (x3.5) includes large- and mid-cap equities from global developed markets.

ERI Scientific Beta, the smart beta index provider offshoot of EDHEC Risk Institute, has announced that assets tracking its indices reached $16.5bn at the end of 30 June 2017, representing an increase of 60% over the past year. A number of ETFs track Scientific Beta indices; the largest of these is the Amundi Global Equity Multi Smart Allocation Scientific Beta UCITS ETF (Euronext: SMRT) which has approximately €500 million in AUM.